Skip to content

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

Press Releases

Choose Year
Search Press Releases

Found 90 Results

June 19, 2020

UPDATE — Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials

June 19, 2020

Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials

May 4, 2020

Surrozen Announces Publication of Two Abstracts Providing Evidence for Liver-Targeted Tissue Regeneration

April 6, 2020

Surrozen Scientific Founder Roel Nusse,PhD Receives Prestigious Canada Gairdner International Award for Biomedical Research

March 30, 2020

Surrozen Announces Publication of Antibody Platform Technology in Cell Chemical Biology

March 2, 2020

Surrozen to Present at Cowen and Company 40th Annual Health Care Conference

April 11, 2019

Surrozen Appoints Dr. Trudy Vanhove as Chief Medical Officer

March 14, 2019

Surrozen Raises $50 Million in Series B Financing to Advance Regenerative Antibody Platforms and Liver Disease Candidates

April 4, 2018

Surrozen Strengthens Leadership Team with Addition of New CEO and Scientific Co-founder

February 15, 2017

Surrozen Launches Into Regenerative Medicine With $33 Million in Series A Financing Led by The Column Group

«...5 6 7 89

IR Contact

Email: investorinfo@surrozen.com

Email Alerts Sign-Up

Email

Unsubscribe

Loading...

Company

About
Management
Board of Directors
Scientific Advisors
Contact
Careers

Science

Science
Pipeline
Publications

Investors

Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs

Copyright © 2026 Surrozen. All Rights Reserved

Privacy Policy
FCOI Policy
Accessibility

Scroll to Top